Inventor
CROOKE STANLEY T
US76 patents
⚠️ This page may combine multiple inventors who share the name “CROOKE STANLEY T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
31 patentsUS7695902B2Apr 13, 2010
Oligoribonucleotides and ribonucleases for cleaving RNA
ISIS PHARMACEUTICALS INC201 citations99
US7629321B2Dec 8, 2009
Oligoribonucleotides and ribonucleases for cleaving RNA
ISIS PHARMACEUTICALS INC146 citations99
US7432250B2Oct 7, 2008
Oligoribonucleotides and ribonucleases for cleaving RNA
ISIS PHARMACEUTICALS INC198 citations99
US7432249B2Oct 7, 2008
Oligoribonucleotides and ribonucleases for cleaving RNA
ISIS PHARMACEUTICALS INC147 citations99
US7255992B2Aug 14, 2007
Methods for rapid detection and identification of bioagents for environmental and product testing
ISIS PHARMACEUTICALS INC154 citations99
US7226739B2Jun 5, 2007
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
ISIS PHARMACEUTICALS INC146 citations99
US7217510B2May 15, 2007
Methods for providing bacterial bioagent characterizing information
ISIS PHARMACEUTICALS INC131 citations99
US6107094AAug 22, 2000
Oligoribonucleotides and ribonucleases for cleaving RNA
ISIS PHARMACEUTICALS INC938 citations99
US5898031AApr 27, 1999
Oligoribonucleotides for cleaving RNA
ISIS PHARMACEUTICALS INC797 citations99
US5457189AOct 10, 1995
Antisense oligonucleotide inhibition of papillomavirus
ISIS PHARMACEUTICALS INC224 citations99
US5248670ASep 28, 1993
Antisense oligonucleotides for inhibiting herpesviruses
ISIS PHARMACEUTICALS INC140 citations99
US7339051B2Mar 4, 2008
Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
ISIS PHARMACEUTICALS INC158 citations98
US5514577AMay 7, 1996
Oligonucleotide therapies for modulating the effects of herpes viruses
ISIS PHARMACEUTICALS INC153 citations98
US6329146B1Dec 11, 2001
Mass spectrometric methods for biomolecular screening
ISIS PHARMACEUTICALS INC93 citations97
US6428956B1Aug 6, 2002
Mass spectrometric methods for biomolecular screening
ISIS PHARMACEUTICALS INC119 citations96
US5681944AOct 28, 1997
Antisense oligonucleotides directed to papillomavirus
ISIS PHARMACEUTICALS INC63 citations96
US6617442B1Sep 9, 2003
Human Rnase H1 and oligonucleotide compositions thereof
ISIS PHARMACEUTICALS INC122 citations95
US5811232ASep 22, 1998
Oligonucleotides for Papillomavirus
ISIS PHARMACEUTICALS INC20 citations93
US5658891AAug 19, 1997
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC36 citations93
US7919612B2Apr 5, 2011
2′-substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC14 citations92
US6969763B1Nov 29, 2005
Molecular interaction sites of interleukin-2 RNA and methods of modulating the same
ISIS PHARMACEUTICALS INC41 citations92
US6656690B2Dec 2, 2003
Mass spectrometric methods for biomolecular screening
ISIS PHARMACEUTICALS INC31 citations92
US6001653ADec 14, 1999
Human type 2 RNase H
ISIS PHARMACEUTICALS INC20 citations92
US5530114AJun 25, 1996
Oligonucleotide modulation of arachidonic acid metabolism
ISIS PHARMACEUTICALS INC46 citations91
US7812149B2Oct 12, 2010
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC12 citations84
US6737512B2May 18, 2004
Human RNase III and compositions and uses thereof
ISIS PHARMACEUTICALS INC15 citations84
US5665580ASep 9, 1997
Antisense oligonucleotide inhibition of papillomavirus transformed cells
ISIS PHARMACEUTICALS INC14 citations82
US6365379B1Apr 2, 2002
Zinc finger peptide cleavage of nucleic acids
ISIS PHARMACEUTICALS INC15 citations79
US6310044B1Oct 30, 2001
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC10 citations74
US6174870B1Jan 16, 2001
Antisense oligonucleotide inhibition of papillomavirus
ISIS PHARMACEUTICALS INC12 citations74
US5756282AMay 26, 1998
Oligonucleotides for the diagnosis of papillomavirus
ISIS PHARMACEUTICALS INC12 citations74
ECKER DAVID J
6 patentsUS8071309B2Dec 6, 2011
Methods for rapid identification of pathogens in humans and animals
ECKER DAVID J37 citations95
US8073627B2Dec 6, 2011
System for indentification of pathogens
ECKER DAVID J24 citations93
US8298760B2Oct 30, 2012
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
ECKER DAVID J7 citations84
US8214154B2Jul 3, 2012
Systems for rapid identification of pathogens in humans and animals
ECKER DAVID J8 citations84
US8822156B2Sep 2, 2014
Methods for rapid identification of pathogens in humans and animals
ECKER DAVID J5 citations83
US8268565B2Sep 18, 2012
Methods for identifying bioagents
ECKER DAVID J8 citations82
IBIS BIOSCIENCES INC
4 patentsUS7781162B2Aug 24, 2010
Methods for rapid identification of pathogens in humans and animals
IBIS BIOSCIENCES INC66 citations98
US7666588B2Feb 23, 2010
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
IBIS BIOSCIENCES INC95 citations98
US7718354B2May 18, 2010
Methods for rapid identification of pathogens in humans and animals
IBIS BIOSCIENCES INC82 citations97
US8046171B2Oct 25, 2011
Methods and apparatus for genetic evaluation
IBIS BIOSCIENCES INC27 citations86
IONIS PHARMACEUTICALS INC
3 patentsUS9827263B2Nov 28, 2017
2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
IONIS PHARMACEUTICALS INC4 citations84
US11149264B2Oct 19, 2021
Modified compounds and uses thereof
IONIS PHARMACEUTICALS INC5 citations83
US10822369B2Nov 3, 2020
Compounds and methods for the modulation of proteins
IONIS PHARMACEUTICALS INC7 citations83
BENNETT C FRANK
2 patentsCROOKE STANLEY T
2 patentsIBIS BIOSCIENCE INC
1 patentMIGAWA MICHAEL T
1 patentShowing the top 50 of 76 patents by PatentIndex Score.